Genesis Molecular AI
Genesis Molecular AI is an artificial intelligence company in Burlingame, United States, founded in 2019. It has raised $256.0M across 3 rounds, most recently a $200.0M Series B in August 2023.
Foundation models for drug discovery
- Headquarters
- Burlingame, California
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- genesis.ml
- Total Funding
- $256.0M
- Last Round
- $200.0M Series BAug 2023
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.
About
Genesis Molecular AI (formerly Genesis Therapeutics) is an AI-first drug discovery and development company headquartered in Burlingame, California. Founded in 2019, the company builds foundation models and an AI operating system — GEMS (Generative AI for Drug Discovery) — for small molecule drug design, integrating generative AI with physics-based modeling to identify potent, selective drug candidates against chemically complex targets at unprecedented speed. Its 3D diffusion foundation model Pearl achieves field-leading performance in drug-protein structure prediction. Genesis operates a fully integrated laboratory in San Diego and partners with major pharmaceutical companies to co-discover and co-develop medicines. The company raised a $200M Series B in 2023 and has partnerships with NVIDIA Healthcare and Incyte.
Summary
It lists 51–200 employees. It has raised $256.0M in total across 3 rounds, most recently a $200.0M Series B round in Aug 2023. Investors include Rock Springs Capital, Andreessen Horowitz and T. Rowe Price.
Tech & App Stack
9 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2023
Sign up to see all 3 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/genesis-molecular-ai"><img src="https://indexed.vc/api/badge/company/genesis-molecular-ai" alt="Genesis Molecular AI on Indexed.vc" width="260" height="76" /></a>